Bepreve is specifically indicated for for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.
Bepreve is supplied as a solution designed for topical administration.
Clinical studies show that 95% of BEPREVE-treated eyes had a clinically significant reduction of itching within minutes after a single drop of BEPREVE. Relief continued for up to 8 hours after dosing.4 Those studies also show that in 68% of eyes with severe itching, BEPREVE provided complete relief in minutes.
Dose: 1 drop in the affected eye(s) twice daily
Supplied: 5 or 10 ml
Pregnancy: Category C
Children: Children ≥2 years of age: 1 drop in the affected eye(s) twice daily.
Side Effects: Adverse events associated with the use of Bepreve may include, but are not limited to, the following:
- mild taste following instillation
- eye irritation